KeyCorp reiterated their buy rating on shares of INC Research (NASDAQ:SYNH) in a research note released on Thursday, January 4th. KeyCorp currently has a $50.00 price objective on the stock.
SYNH has been the topic of several other reports. Zacks Investment Research downgraded shares of INC Research from a buy rating to a hold rating in a research report on Wednesday, October 4th. Credit Suisse Group started coverage on shares of INC Research in a research report on Wednesday, October 11th. They issued an outperform rating and a $68.00 target price on the stock. Jefferies Group reissued a buy rating and issued a $55.00 target price on shares of INC Research in a research report on Friday, November 10th. TheStreet raised shares of INC Research from a c rating to a b- rating in a research report on Monday, November 6th. Finally, Robert W. Baird set a $46.00 price target on shares of INC Research and gave the stock a buy rating in a report on Thursday, November 16th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have given a buy rating to the stock. INC Research presently has a consensus rating of Buy and an average price target of $50.78.
INC Research (NASDAQ:SYNH) opened at $40.95 on Thursday. The stock has a market cap of $4,403.36, a PE ratio of -70.60, a PEG ratio of 1.30 and a beta of 1.09. INC Research has a 52-week low of $33.60 and a 52-week high of $61.10. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.27 and a quick ratio of 1.27.
INC Research (NASDAQ:SYNH) last released its quarterly earnings results on Thursday, November 9th. The company reported $0.54 EPS for the quarter, missing analysts’ consensus estimates of $0.63 by ($0.09). The company had revenue of $592.21 million for the quarter, compared to the consensus estimate of $604.95 million. INC Research had a positive return on equity of 14.42% and a negative net margin of 4.29%. The firm’s quarterly revenue was up 128.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.64 earnings per share. research analysts anticipate that INC Research will post 2.15 earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: This piece of content was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2018/01/13/inc-research-incr-rating-reiterated-by-keycorp.html.
INC Research Company Profile
Syneos Health, Inc, formerly INC Research Holdings, Inc, is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.
Receive News & Ratings for INC Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research and related companies with MarketBeat.com's FREE daily email newsletter.